Back to Diseases & Conditions

Fatty liver disease (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called nonalcoholic fatty liver disease (NAFLD), is a liver condition that affects people with excess weight, obesity or other metabolic conditions, such as type 2 diabetes, high blood pressure or high cholesterol. In MASLD, too much fat builds up in the liver.

MASLD is becoming more common, especially in Middle Eastern and Western nations, as the number of people with obesity rises. It is the most common form of liver disease in the world. MASLD ranges in severity from hepatic steatosis — sometimes called diffuse hepatic steatosis, or formerly fatty liver infiltration or simply fatty liver — to a more severe form of disease called metabolic dysfunction-associated steatohepatitis (MASH), formerly called nonalcoholic steatohepatitis (NASH).

MASH causes the liver to swell or enlarge. This is known as hepatomegaly. MASH also causes fat deposits in the liver, which causes liver damage. MASH may get worse and may lead to serious liver scarring, called cirrhosis, or even liver cancer. This damage is like the damage caused by heavy alcohol use.

Life expectancy varies depending on whether you have MASLD or MASH. Factors such as scarring and other health conditions also affect how long you can live with MASLD or MASH.

MASLD often has no symptoms. When it does, they include:

Possible symptoms of MASH and cirrhosis, which is severe scarring, include:

When to see a doctor

Make an appointment with a member of your health care team if you have lasting symptoms that worry you.

Experts don’t know exactly why fat builds up in some livers and not others. They also don’t fully understand why fat buildup in some livers turns into MASH.

MASLD and MASH are both linked to the following:

These combined health concerns may contribute to liver damage. However, some people get MASLD even if they do not have any risk factors.

Many diseases and health conditions can increase your risk of MASLD, including:

MASH is more likely in people:

It is hard to tell MASLD and MASH apart without an exam and testing.

Severe liver scarring, also called cirrhosis, is the main complication of MASLD and MASH. Cirrhosis happens because of liver injury, such as the damage caused by inflammation in MASH. As the liver tries to stop inflammation, it creates areas of scarring, also called fibrosis. With ongoing inflammation, fibrosis spreads and takes up more liver tissue.

If nothing is done to stop the scarring, cirrhosis can lead to:

For many people with MASLD, the outlook is good, especially if they make recommended lifestyle changes. In fact, in some people, weight loss may help reverse MASLD. However, some people develop MASH, which significantly impacts life expectancy and health outcomes.

To reduce your risk of MASLD:

Because MASLD typically causes no symptoms, it is often found when tests done for other reasons point to a liver condition. For example, a blood test done during a yearly exam may show high levels of liver enzymes, which can prompt more testing that leads to a MASLD diagnosis.

Tests done to diagnose MASLD, rule out other diseases and see how bad the liver damage is include:

Blood tests

Imaging procedures

Imaging tests used to diagnose MASLD include:

Liver biopsy

If other tests show signs of MASH, or if your test results are unclear, your healthcare professional may suggest a liver biopsy. Liver biopsy is a procedure to remove a small piece of tissue from your liver. It is usually done using a needle passed through the abdominal wall. The tissue sample is looked at in a lab for signs of inflammation and scarring. Liver biopsy is a way to diagnose MASH and find out the amount of liver damage, but in most people, noninvasive imaging tests are used instead.

You may feel some discomfort with a liver biopsy, and it does have risks that your healthcare team talks about with you in detail.

Treatment for MASLD usually starts with weight loss. This can be done by eating a healthy diet, limiting portion sizes and exercising. Losing weight may improve other health conditions that can lead to MASLD. Typically, losing 10% of your body weight or more is recommended. But losing even 3% to 5% of your starting weight can have benefits.

Two medicines are available to treat people who have MASH with moderate to severe liver scarring. Resmetirom (Rezdiffra) and semaglutide can help reduce the amount of fat and scarring in the liver. These medicines are not recommended for people with cirrhosis. People who have cirrhosis due to MASH may need a liver transplant.

With help from your health care team, you can take steps to manage nonalcoholic fatty liver disease. You can:

No alternative medicine treatments are proved to cure MASH or MASLD. But researchers are studying whether some supplements or natural compounds could be helpful, such as:

See your family or primary healthcare professional first if you have symptoms that worry you. If a liver problem such as MASLD or MASH is suspected, you may be referred to a doctor who specializes in the liver, called a hepatologist.

Because appointments can be short, it’s a good idea to be well prepared. Here are a few tips to help you get ready, and what to expect from your healthcare professional.

What you can do

If you find out you have MASH or MASLD, some basic questions to ask include:

In addition to the questions that you’ve prepared to ask your care team, don’t hesitate to ask questions during your appointment.

What to expect from your doctor

Your healthcare professional is likely to ask you a number of questions, such as:

© 1998-2024 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.

We Make Health Possible

As East Central Indiana’s population grows, we’re putting health care where people need it most. Besides Hancock Regional Hospital, ranked as one of the nation’s safest by the Lown Hospital Index, our network includes more than 30 otros lugares cerca de tu casa o trabajo.

Learn More about Hancock